Skip to main content
Annals of Saudi Medicine logoLink to Annals of Saudi Medicine
. 2008 Jul-Aug;28(4):1–2. doi: 10.5144/0256-4947.2008.304

Diagnosis: Pulmonary alveolar microlithiasis after exposure to mustard gas

Mohammad A Rajabi 1,
PMCID: PMC6074359

Pulmonary alveolar microlithiasis (PAM) is a rare disease of unknown etiology and pathogenesis. 2,3 This disorder is characterized by intra-alveolar development and deposition of microliths or calcispherytes containing calcium phosphate.2,3 The age range of patients is from newborn to 80 years. The mean age at presentation is in the third to fourth decade with no sexual predominance, but in approximately half the reported cases a familial pattern has been found. Most of the patients have few or no symptoms despite the gross radiographic changes. The dissociation between the definite x-ray pattern of the lungs and the relatively poor clinical symptoms is the most common characteristic of this disease. However, a certain degree of dyspnea with productive cough may occur together with a sporadic hemoptysis, thoracic pain and sometimes spontaneous pneumothorax.4,5 The lungs are hardened with associated deterioration of pulmonary hypertension and thus cor pulmonale occurs.6 Pulmonary fibrosis is also observed in association with PAM.7,8 In such cases, as in our patient, a posteroanterior chest x-ray shows a dissemination of radio-opaque nodules of almost equal sizes and the lungs appear to be sprinkled with sand. Very fine sand-like micronodulations with calcified densities were observed throughout both lungs fields (Figure 1). Histological examination demonstrated onion-skin-like microliths occupying the alveoli. Amorphous eosinophilic material filled the alveoli (Figure 2).

Figure 1.

Figure 1

Chest x-ray showing bilateral apical bullae, diseeminated sand-like discrete radio-opaque micronodules predominantly in the lower zones. Lungs appear to be sprinkled with sand.

Figure 2.

Figure 2

Photomicrograph showing laminated appearance of a microlith (hematoxylineosin, ×40).

Some authors suggested that PAM may be a peculiar exudative response to a variety of insults, which include pneumonia and rheumatic fever.911 Our report describes PAM after exposure to mustard gas. In other cases of microlithiasis sandstorm-associated, the exact cause has not been proved; only in 50% of cases has a genetic or familial factor been reported, but other causes have not been confirmed. In all cases, either acquired or genetic, it can be assumed that there is a disorder in the bronchial cilia or alveolar endothelium. Therefore, it can be concluded that acquired causes can induce enzymatic disorders similar to those in genetic defects.4

Although the clinical features of this disease have been well described, the mechanism which may induce microliths to form is unknown. Inhalation of specific powders was thought to be involved in the origin of microliths as some patients lived in the same rural district and worked on the same farmlands. In addition, the pattern of serial scans clearly indicated that the lung mucociliary function was impaired in patients with microlithiasis. This may suggest that slowing of the clearance may represent a pathogenetic factor capable of favoring the formation of alveolar microliths. In patients who smoke “snuff “ (a particular mixture of tobacco and oriental gum) this hypothesis is favored. Finally, cases of PAM secondary to lung cancer, tubercular remains and pleural mesothelioma have also been reported.4

The etiology of pulmonary alveolar microlithiasis has remained obscure;115 however, familial occurrence is a notable feature and has been observed in more than half of reported cases.15 However, our patient did not have a familial history of PAM or any other pulmonary disorders. His previous lab tests and chest roentgenograms showed a normal pulmonary condition before the exposure to mustard gas. His symptoms and roentgenographic changes appeared after the exposure to mustard gas. The pattern observed in his chest x-ray consisted of disseminated uniform fine radio-opaque nodules. Our initial diagnosis was miliary tuberculosis as the radiologic pattern is somewhat similar.1114 However, as the patient did not have other features of tuberculosis, the diagnosis of microlithiasis was suggested and then confirmed by lung biopsy. The diagnosis of microlithiasis can be confirmed by bronchoalveolar lavage (BAL) or lung biopsy.13,14

It is notable that a miliary pattern on chest roentgenograms may be seen in disseminated tuberculosis, fungal infection, neoplastic processes, sarcoidosis, pneumoconiosis, hemosiderosis, amyloidosis and metastatic pulmonary calcification associated with chronic renal failure and hemodialysis.3,14 These diseases, however, are usually associated with severe respiratory symptoms, whereas the peculiar feature of PAM is its asymptomatic nature and the paucity of physical signs, which are difficult to correlate with the gross roentgenographic abnormality.15,16

For treatment of pulmonary microlithiasis, the use of diphosphonate to reduce calcium phosphate precipitation in pulmonary alveolus is suggested.117 This treatment would have induced only a trivial improvement in the x-ray pattern without any improvement in the evaluative course of the disease.316 The use of steroids is ineffective and the use of therapeutic bronchoalveolar lavage fluid (BAL) is controversial.119 There are reports of lung transplantation for end-stage lung diseases.13, 19

REFERENCES

  • 1.Gocmen A, Toppare MF, Kiper N. Treatment of pulmonary alveolar microlithiasis with a diphosphonate. Respiration. 1992;59:250–254. doi: 10.1159/000196068. [DOI] [PubMed] [Google Scholar]
  • 2.Castellana G, Lamorgese V. Pulmonary alveolar microlithiasis. Respiration. 2003;70:549–555. doi: 10.1159/000074218. [DOI] [PubMed] [Google Scholar]
  • 3.Mariotta S, Ricci A, Papale M, et al. Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:173–181. [PubMed] [Google Scholar]
  • 4.Lauta MV. Pulmonary alveolar microlithiasis: an overview of clinical and pathological features together with possible therapies. Respir med. 2003;97:1081–1085. doi: 10.1016/s0954-6111(03)00140-9. [DOI] [PubMed] [Google Scholar]
  • 5.Shishido S, Toritani T, Nakano H, et al. A case of alveolar microlithiasis which developed spontaneous pneumothorax due to progression of emphysematous bullae during 34 years after established diagnosis. Nihon Kyobu Shikkan Gakkai Zasshi. 1993;31:881–885. [PubMed] [Google Scholar]
  • 6.Synetos A, Dilaveris P, Gialafos E, et al. severe pulmonary hypertension due to pulmonary alveolar microlithiasis. Int J Cardiol. 2006;26:396–397. doi: 10.1016/j.ijcard.2004.12.084. [DOI] [PubMed] [Google Scholar]
  • 7.Corut A, Senyigit A, Ugur SA, et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet. 2006;79:650–656. doi: 10.1086/508263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Castellana G, Gentile M, Castellana R, et al. Pulmonary alveolar microlithiasis: clinical features, evolution of the phenotype, and review of the literature. Am J Medical Genetics. 2002;111:220–224. doi: 10.1002/ajmg.10530. [DOI] [PubMed] [Google Scholar]
  • 9.Sampsonas F, Karkoulias K, Kaparianos T, Tsiamita M, et al. Pulmonary Alveolar Microlithiasis in a Patient with Rheumatic Valvular Heart Disease. Am J Med Scien. 2007;334:128–130. doi: 10.1097/MAJ.0b013e31812e4bbd. [DOI] [PubMed] [Google Scholar]
  • 10.Brandenburg VM, Schubert H. images in clinical medicine: pulmonary alveolar microlithiasis. N Engl J Med. 2003;348:1555–1558. doi: 10.1056/NEJMicm020034. [DOI] [PubMed] [Google Scholar]
  • 11.Haruko M, Isao Y, Miyuki K, et al. A case of pulmonary alveolar microlithiasis with a high concentration of pulmonary surfactant apoproteins A and D in serum. Respiration Research. 2000;19:176–180. [Google Scholar]
  • 12.Þenyiðit A, Yaramis A, Gurkan F, et al. Pulmonary alveolar microlithiasis: a rare familial inheritance with report of six cases in a family. Contribution of six new cases to the number of case reports in Turkey. Respiration. 2001;68:204–209. doi: 10.1159/000050494. [DOI] [PubMed] [Google Scholar]
  • 13.Agarwal R, Agarwal AN, Gupta D. pulmonary snowstorm. Internal medicine Journal. 2007;37:416–417. doi: 10.1111/j.1445-5994.2007.01376.x. [DOI] [PubMed] [Google Scholar]
  • 14.Moran CA, Hochholzer L, Hasleton PS, Johnson FB, et al. Pulmonary alveolar microlithiasis. A clinicopathologic and chemical analysis of seven cases. Arch Pathol Lab Med. 1997;121:607–611. [PubMed] [Google Scholar]
  • 15.Erelel M, Kiyan E, Cuhadaroglu C, et al. Pulmonary alveolar lithiasis in two siblings. Respiration. 2001;68:327–330. doi: 10.1159/000050520. [DOI] [PubMed] [Google Scholar]
  • 16.Shah MS, Nanavati KJ, Airon A, et al. Case report-pulmonary alveolar microlithiasis. Ind J Radiol Imag. 2003;13:277–279. [Google Scholar]
  • 17.Barbolini G, Rossi G. Pulmonary alveolar microlithiasis. N Engl J Med. 2002;347:69–70. doi: 10.1056/NEJM200207043470118. [DOI] [PubMed] [Google Scholar]
  • 18.Ortakåylè G, Ketenci A, Ayse B, et al. Pulmonary Alveolar Microlithiasis. Turkish Respiratory Journal. 2006;7:034–037. [Google Scholar]
  • 19.Stamatis G, Zerkowski HR, Doetsch N, Greschuchna D, et al. Sequential bilateral lung transplantation for pulmonary alveolar microlithiasis. Ann Thorac Surg. 1993;56:972–975. doi: 10.1016/0003-4975(93)90370-w. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Saudi Medicine are provided here courtesy of King Faisal Specialist Hospital and Research Centre

RESOURCES